Johannes A Govaert1, Wouter A van Dijk2, Marta Fiocco3, Alexander C Scheffer4, Lieke Gietelink5, Michel W J M Wouters6, Rob A E M Tollenaar5. 1. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Surgery, Groene Hart Ziekenhuis, Gouda, The Netherlands. Electronic address: j.a.govaert@lumc.nl. 2. Performation, Bilthoven, The Netherlands; X-IS, Delft, The Netherlands. 3. Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands; Mathematical Institute, Leiden University Medical Center, Leiden, The Netherlands. 4. Performation, Bilthoven, The Netherlands. 5. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. 6. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Recent literature suggests that focus in health care should shift from reducing costs to improving quality; where quality of health care improves, cost reduction will follow. Our primary aim was to investigate whether improving the quality of surgical colorectal cancer care, by using a national quality improvement initiative, leads to a reduction of hospital costs. STUDY DESIGN: This was a retrospective analysis of clinical and financial outcomes after colorectal cancer surgery in 29 Dutch hospitals (9,913 patients). Detailed clinical data were obtained from the 2010 to 2012 population-based Dutch Surgical Colorectal Audit. Patient-level costs were measured uniformly in all participating hospitals and based on time-driven, activity-based costing. Odds ratios (OR) and relative differences (RD) were risk adjusted for hospitals and differences in patient characteristics. RESULTS: Over 3 consecutive years, severe complications and mortality declined by 20% (risk-adjusted OR 0.739, 95% CI 0.653 to 0.836, p < 0.001), and 29% (risk-adjusted OR 0.757, 95% CI 0.571 to 1.003, p = 0.05), respectively. Simultaneously, costs during primary admission decreased 9% (risk-adjusted RD -7%, 95% CI -10% to -5%, p < 0.001) without an increase in costs within the first 90 days after discharge (RD -2%, 95% CI -10% to 6%, p = 0.65). An inverse relationship (at hospital level) between severe complication rate and hospital costs was identified (R = 0.64). Hospitals with increasing severe complication rates (between 2010 and 2012) were associated with increasing costs; hospitals with declining severe complication rates were associated with cost reduction. CONCLUSIONS: This report presents evidence for simultaneous quality improvement and cost reduction. Participation in a nationwide quality improvement initiative with continuous quality measurement and benchmarked feedback reveals opportunities for targeted improvements, bringing the medical field forward in improving value of health care delivery. The focus of health care should shift to improving quality, which will catalyze costs savings as well.
BACKGROUND: Recent literature suggests that focus in health care should shift from reducing costs to improving quality; where quality of health care improves, cost reduction will follow. Our primary aim was to investigate whether improving the quality of surgical colorectal cancer care, by using a national quality improvement initiative, leads to a reduction of hospital costs. STUDY DESIGN: This was a retrospective analysis of clinical and financial outcomes after colorectal cancer surgery in 29 Dutch hospitals (9,913 patients). Detailed clinical data were obtained from the 2010 to 2012 population-based Dutch Surgical Colorectal Audit. Patient-level costs were measured uniformly in all participating hospitals and based on time-driven, activity-based costing. Odds ratios (OR) and relative differences (RD) were risk adjusted for hospitals and differences in patient characteristics. RESULTS: Over 3 consecutive years, severe complications and mortality declined by 20% (risk-adjusted OR 0.739, 95% CI 0.653 to 0.836, p < 0.001), and 29% (risk-adjusted OR 0.757, 95% CI 0.571 to 1.003, p = 0.05), respectively. Simultaneously, costs during primary admission decreased 9% (risk-adjusted RD -7%, 95% CI -10% to -5%, p < 0.001) without an increase in costs within the first 90 days after discharge (RD -2%, 95% CI -10% to 6%, p = 0.65). An inverse relationship (at hospital level) between severe complication rate and hospital costs was identified (R = 0.64). Hospitals with increasing severe complication rates (between 2010 and 2012) were associated with increasing costs; hospitals with declining severe complication rates were associated with cost reduction. CONCLUSIONS: This report presents evidence for simultaneous quality improvement and cost reduction. Participation in a nationwide quality improvement initiative with continuous quality measurement and benchmarked feedback reveals opportunities for targeted improvements, bringing the medical field forward in improving value of health care delivery. The focus of health care should shift to improving quality, which will catalyze costs savings as well.
Authors: Lucas W Thornblade; Thomas K Varghese; Xu Shi; Eric K Johnson; Amir Bastawrous; Richard P Billingham; Richard Thirlby; Alessandro Fichera; David R Flum Journal: Dis Colon Rectum Date: 2017-01 Impact factor: 4.585
Authors: Liset Lansaat; Vincent van der Noort; Simone E Bernard; Simone E J Eerenstein; Boudewijn E C Plaat; Ton A P M Langeveld; Martin Lacko; Frans J M Hilgers; Remco de Bree; Robert P Takes; Michiel W M van den Brekel Journal: Eur Arch Otorhinolaryngol Date: 2018-01-16 Impact factor: 2.503
Authors: Evelien M Sandberg; Wouter J K Hehenkamp; Peggy M Geomini; Petra F Janssen; Frank Willem Jansen; Andries R H Twijnstra Journal: Arch Gynecol Obstet Date: 2017-07-26 Impact factor: 2.344
Authors: D C Eindhoven; L N van Staveren; J A van Erkelens; D E Ikkersheim; S C Cannegieter; V A W M Umans; A Mosterd; J van Wijngaarden; M J Schalij; C J W Borleffs Journal: Neth Heart J Date: 2018-01 Impact factor: 2.380
Authors: Jeroen T J M van Dijck; Cassidy Q B Mostert; Alexander P A Greeven; Erwin J O Kompanje; Wilco C Peul; Godard C W de Ruiter; Suzanne Polinder Journal: Acta Neurochir (Wien) Date: 2020-05-14 Impact factor: 2.216